Career Development

Whether you are a resident, a young urologist or an experienced specialist, your career can benefit from an EAU Membership. The EAU supports you throughout your career with programmes for continuing medical education and certification. For young and upcoming EAU members we offer several educational programmes, scholarships and clinical visits. Members have advanced access to the Resource Centre.

Free Access to Guidelines

For any successful clinician, having the most up-to-date evidence-based recommendations on hand is crucial for the successful treatment of your patients. The EAU Guidelines are unparalleled in that regard, used all across the world. They are comprehensively updated on an annual basis and freely accessible for all members.


Urologists are bound by national and, increasingly, international laws that govern treatment options and patient care. The EAU brings together the voices of medical professionals, researchers, innovators and patients on a European platform to keep urological topics on the agendas of the authorities.

Networking with Peers

The EAU offers a wide range of events and courses to interact with the best specialists in the field of urology. The Annual EAU Congress is the largest urology-related event in the world where you can network with like-minded professionals.

Latest Research

Our journal, European Urology, has been a prestigious urological forum for over 35 years, and is currently read by more than 20,000 urologists. It is one of the most widely-cited medical journals in the world and, with an impact factor of 13.938, leading in its field. Members have free access to full-text articles.

Uroweb About European Association of Urology

For almost 40 years the EAU has addressed the most pressing issues of urological care in Europe, through its scientific and educational initiatives, as well as its publications. Become a member and get access to the benefits:

Member benefits

Latest News

KIDNEY cancer session CCC

CEM15: Surgical limits in metastatic kidney cancer

Not all patients with advanced kidney cancer would benefit from nephrectomy, prompting experts to consider other less radical or aggressive options such as partial nephrectomy or lymph node dissection. “Partial nephrectomy should be considered standard of care whenever possible...

Latest Videos

  • ERUS15-Compilation

    Looking back at Bilbao

    The EAU Robotic Urology Section (ERUS) had its 12th annual meeting in Bilbao. Head of the Local Organising Committee, Dr. José Pereira Arias made this impression of the event.

  • YoutubecbdLgEX8_pU

    EAU15: New Era at EAU – Chris Chapple

    EAU TV spoke to the incoming Secretary General of the EAU, Chris Chapple about his plans for the coming years, and building on the existing strengths of the EAU.

  • YoutubeU2lTjppUI0w

    Dr. Joan Palou about the European School of Urology (ESU)

    This video gives on overview of the urological educational material, that the ESU has to offer, ranging from accredited e-courses, surgical videos, online preparation for Hands-on-Training courses, guidelines, publications and scientific content from our events.

  • YoutubeKZclDfYf8jc

    Mikkel Fode about realistic outcomes after prostatectomy

    EAU TV spoke to Mikkel Fode, Faculty of Health Science, University of Copenhagen, Denmark whose research into patients own perceptions of return to erectile function after radical prostatectomy casts a new light on the outcomes of the surgery.

  • YoutubefbKySKJ6ods

    From Far and Wide – EAUs International sessions

    The first day of the EAU 2015 conference saw meetings from many other urology associations from around the world, including China, Iran, and South America. We caught up with some of their members about why EAU 15 is such an important event to come to.

  • YoutubeLXFXcmCNfc0

    EAU15: Chris Probert about Sniffing Cancer

    EAU TV spoke to Chris Probert, Professor, Institute of Translational Medicine, University of Liverpool at EAU 15 about the new technology he’s working on to smell volatile urinary compounds in cancer patients.